Detection of ticarcillin-clavulonic acid susceptibility with microdilution method in Citrobacter, Hafnia, Proteus and some gram negative bacteria

Drug Metabolism and Drug Interactions

Volumn 20, Issue 3, 2004, Pages 185-191

  Uraz, Güven ^a   Öncül, Özlem ^a  

^a GAZI UNIVERSITY   (Turkey)

Author keywords

Aeromonas; Antibiotic susceptibility test; Citrobacter; Hafnia; Microdilution method; Minimal inhibitory concentration; Morganella; Proteus; Pseudomonas; Ticarcillin clavulonic acid

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AZTREONAM; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; GENTAMICIN; IMIPENEM; NETILMICIN; TIMENTIN;

AEROMONAS; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATION; BROTH DILUTION METHOD; CITROBACTER; DILUTION; GRAM NEGATIVE BACTERIUM; HAFNIA; HUMAN; ISOLATION PROCEDURE; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA; NONHUMAN; PROTEUS; PSEUDOMONAS; STRAIN IDENTIFICATION;

EID: 6344255205     PISSN: 07925077     EISSN: None     Source Type: Journal    
DOI: 10.1515/DMDI.2004.20.3.185     Document Type: Article

References (11)

1. Handfield M, Schangring F, Hoang T. ASD-GFP vectors for in vitro expression technology in P. aeuroginosa and other Gram negative bacteria. Biotechniques 1998; 24: 261-264.
2. NCCLS. National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Test for Bacteria that Grow Aerobically. Approved Standard, Document: M7-A4, Wayne, 1997.
3. Pineiro SA, Sordelli DO, Centron D. Development of a plasmid vector for easy selection of strong promoters. Curr Microbiol 2000; 40: 302-305.
4. Monnet D, Richard C. Autres enterobacteriaceae. In: Freney J, Renaud F, Hansen W, Bolled C, eds. Manuel de Bacteriologie Clinique, 2nd Ed. Paris: Elsevier E S, 1994; 1053-1128.
5. Barorro H, Duarte A. Molecular characterization of a ceftazidime- resistant Morganella morganii isolate producing a TEM-10-lactamase. Antimicrob Agents Chemother 1999; 43: 434-435.
6. Philippen LN, Naas T, Bouthors A, Barakett V, Nordmann P. OXA-18, a class D clavulanic-acid inhibited extended-spectrum β-lactamase from Pseudomonas aeruginosa. Antimicrob Agents Chemother 1997; 41: 2188-2195.
7. Mimoz O, Jacolot A, Leotard S, Hidri N, Samii N, Nordmann P, Petitjean O. Efficacies of cefepime, ceftazidime, and imipenem alone or in combination with amikacin in rats with experimental pneumonia due to ceftazidime-susceptible or resistant Enterobacter cloacae strains. Antimicrob Agents Chemother 1998; 42: 3304-3308.
8. Arpin C, Labia R, Dubois V, Noury P, Souquet M, Quentin C. TEM-80, a novel inhibitor-resistant β-lactamase in a clinical isolate of Enterobacter cloacae. Antimicrob Agents Chemother 2002; 46: 1183-1189.
9. Gould IM, Milne K. First six-month report on the cystic fibrosis antibiotic susceptibility service. In: Lactation, SCIEH Weekly Report 1999; Vol. 33 (99/49): 314-316.
10. Stetsiouk O, Galkin D, Ryabkova E, Kretchikova O, Stratchounski L. Antimicrobial Susceptibility (AS) of Bacteria Causing Complicated Intra-Abdominal Infections (CIAI). Institute Antimicrobial Agents of Chemotherapy, Smolensk State Medical Academy, Russia, 2003; 979.
11. Yano H, Kuga A, Irinoda K, Okamoto R, Kobayashi T, Inoue M. Plasmid encoded metallo-β-lactamase (IMP-6) conferring resistance to carbapenems, especially meropenem. Antimicrob Agents Chemother 2001; 45: 1343-1348.